| |
|
|
|
18:15 |
MRDR
Business Meeting |
Michael
D. Cockman, Ph.D., Chair |
|
|
|
|
|
18:30
|
Lecture:
Employing MR Techniques for Objective Assessment of Liver
Fibrosis |
Richard
L. Ehman, M.D.
Mayo Clinic
Rochester, MN, USA
(Patricia E. Cole, M.D., Ph.D., Chair) |
|
|
|
|
|
19:00 |
Lecture:
MRI of Myocardial Fibrosis from a Cellular Level to Clinical
Reality |
Andrew E.
Arai, M.D.
NHLBI
Bethesda, MD, USA
(Béat
M. Jucker, Ph.D., Chair) |
|
|
|
|
|
19:30 |
Debate
Topic: |
(Michael
D. Cockman, Ph.D., Chair) |
|
|
What is Needed to Make Pre-Clinical MRI More Viable for Drug
Development Studies?
Participants from Agilent Technologies, Bruker BioSpin and
the pharmaceutical industry.
Case studies: |
|
|
-
Application of DCE-MRI to tumor models
-
Application of ASL for brain studies
|
|
|
20:15 |
Adjourn |
|
|
|
|
|
|